|
CH658973A5
(fr)
*
|
1983-12-29 |
1986-12-31 |
Nestle Sa |
Produit aromatisant.
|
|
JPS6197229A
(ja)
*
|
1984-10-18 |
1986-05-15 |
Chugai Pharmaceut Co Ltd |
安定なエリトロポエチン製剤
|
|
JPS63146828A
(ja)
*
|
1986-07-18 |
1988-06-18 |
Chugai Pharmaceut Co Ltd |
安定な顆粒球コロニ−刺激因子含有製剤
|
|
DE3729863A1
(de)
*
|
1987-09-05 |
1989-03-16 |
Boehringer Mannheim Gmbh |
Stabilisierte erythropoietin-lyophilisate
|
|
JPS649938A
(en)
|
1987-06-30 |
1989-01-13 |
Agency Ind Science Techn |
Oral ingestive composition
|
|
JPH03505334A
(ja)
|
1989-04-11 |
1991-11-21 |
イミユノバイオロジー・リサーチ・インスチチユート・インコーポレーテツド |
凍結乾燥されたペプチド製剤
|
|
IT1240314B
(it)
|
1989-09-28 |
1993-12-07 |
Immunobiology Research Institutes, Inc. |
Formulazioni acquose stabilizzate di piccoli peptidi.
|
|
US5221495A
(en)
*
|
1990-04-13 |
1993-06-22 |
Colgate-Palmolive Company |
Enzyme stabilizing composition and stabilized enzyme containing built detergent compositions
|
|
US5451410A
(en)
|
1993-04-22 |
1995-09-19 |
Emisphere Technologies, Inc. |
Modified amino acids for encapsulating active agents
|
|
US6284727B1
(en)
*
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
|
US5681811A
(en)
|
1993-05-10 |
1997-10-28 |
Protein Delivery, Inc. |
Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
US5654278A
(en)
*
|
1994-10-13 |
1997-08-05 |
Novo Nordisk A/S |
Composition and method comprising growth hormone and leucine
|
|
US5593696A
(en)
*
|
1994-11-21 |
1997-01-14 |
Mcneil-Ppc, Inc. |
Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
|
|
US5904935A
(en)
|
1995-06-07 |
1999-05-18 |
Alza Corporation |
Peptide/protein suspending formulations
|
|
ZA965368B
(en)
*
|
1995-07-14 |
1997-01-14 |
Novo Nordisk As |
A pharmaceutical formulation
|
|
US5932547A
(en)
|
1996-07-03 |
1999-08-03 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
|
US5916582A
(en)
|
1996-07-03 |
1999-06-29 |
Alza Corporation |
Aqueous formulations of peptides
|
|
AU737664B2
(en)
|
1996-07-03 |
2001-08-30 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
|
US6541606B2
(en)
|
1997-12-31 |
2003-04-01 |
Altus Biologics Inc. |
Stabilized protein crystals formulations containing them and methods of making them
|
|
US6087478A
(en)
*
|
1998-01-23 |
2000-07-11 |
The Rockefeller University |
Crystal of the N-terminal domain of a STAT protein and methods of use thereof
|
|
JP2002521322A
(ja)
|
1998-07-23 |
2002-07-16 |
ノボ ノルディスク アクティーゼルスカブ |
安定な医薬製剤の製造のための湿式顆粒化方法
|
|
MXPA01005346A
(es)
|
1998-11-27 |
2003-03-27 |
Kanji Takada |
Una formulacion oral para suministro de farmaco gastrointestinal.
|
|
US6734162B2
(en)
|
2000-01-24 |
2004-05-11 |
Minimed Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
|
JP2004501191A
(ja)
*
|
2000-06-28 |
2004-01-15 |
テバ ファーマシューティカル インダストリーズ リミティド |
カルベジロール
|
|
FR2811884B1
(fr)
|
2000-07-21 |
2003-01-31 |
Oreal |
Utilisation en cosmetique de betainates d'amidon et composition les comprenant associes a au moins un agent benefique pour les matieres keratiniques
|
|
US6613308B2
(en)
*
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
AU2001296389A1
(en)
|
2000-09-29 |
2002-04-08 |
Cognetix, Inc. |
Stable peptide formulations
|
|
EP1351704B1
(en)
|
2000-12-21 |
2007-03-07 |
Nektar Therapeutics |
Storage stable powder compositions of interleukin-4 receptor
|
|
CA2435835A1
(en)
|
2001-02-02 |
2002-08-15 |
Pharmacia Corporation |
Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
|
|
GB0104371D0
(en)
*
|
2001-02-22 |
2001-04-11 |
Clariant Int Ltd |
Color improving stabilizing compositions comprising leucine
|
|
US6573237B2
(en)
|
2001-03-16 |
2003-06-03 |
Eli Lilly And Company |
Protein formulations
|
|
CA2905585C
(en)
*
|
2001-03-29 |
2020-02-18 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists for the treatment and/or prevention of cancer or polyps
|
|
AU2002355542A1
(en)
|
2001-08-09 |
2003-02-24 |
Doctor's Signature Sales And Marketing International Corp. ((Dba)) Life Force International |
Protonic formulation
|
|
US20030104996A1
(en)
*
|
2001-08-30 |
2003-06-05 |
Tiansheng Li |
L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
|
|
US20040161776A1
(en)
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
|
AU2002351755A1
(en)
*
|
2001-12-21 |
2003-07-15 |
Novo Nordisk A/S |
Liquid composition of modified factor vii polypeptides
|
|
JP2003201256A
(ja)
|
2001-12-28 |
2003-07-18 |
Hisamitsu Pharmaceut Co Inc |
大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
|
|
DE10261126A1
(de)
*
|
2002-08-13 |
2004-03-04 |
Aventis Behring Gmbh |
Lagerungsstabile, flüssige Fibrinogen-Formulierung
|
|
PL377479A1
(pl)
|
2002-12-11 |
2006-02-06 |
Pfizer Products Inc. |
Kontrolowane uwalnianie substancji czynnej do środowiska o wysokiej zawartości tłuszczu
|
|
US7371727B2
(en)
*
|
2003-01-28 |
2008-05-13 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
US7304036B2
(en)
*
|
2003-01-28 |
2007-12-04 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
EP1911763B1
(en)
*
|
2003-01-28 |
2010-08-11 |
Ironwood Pharmaceuticals, Inc. |
Compositions for the treatment of gastrointestinal disorders
|
|
ATE390142T1
(de)
*
|
2003-05-14 |
2008-04-15 |
Indus Biotech Pvt Ltd |
Synergistische zusammensetzung zur behandlung von diabetes mellitus
|
|
EP1641486B1
(en)
*
|
2003-06-10 |
2012-04-18 |
LG Life Sciences Ltd. |
Stable, aqueous solution of human erythropoietin, not containing serum albumin
|
|
JP2007501866A
(ja)
|
2003-06-13 |
2007-02-01 |
マイクロバイア インコーポレイテッド |
胃腸疾患の治療のための方法および組成物
|
|
US7494979B2
(en)
|
2003-06-13 |
2009-02-24 |
Ironwood Pharmaceuticals, Inc. |
Method for treating congestive heart failure and other disorders
|
|
KR100560697B1
(ko)
|
2003-08-06 |
2006-03-16 |
씨제이 주식회사 |
알부민을 함유하지 않는 에리스로포이에틴 제제
|
|
DE202004020676U1
(de)
*
|
2004-03-10 |
2005-11-10 |
Bioceuticals Arzneimittel Ag |
Erythropoietin-Flüssigformulierung
|
|
WO2006071102A1
(en)
|
2004-12-30 |
2006-07-06 |
Dobeel Co., Ltd. |
Spray-dried composition containing collectin family proteins or variants therof and process for preparing the same
|
|
WO2007022531A2
(en)
*
|
2005-08-19 |
2007-02-22 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
WO2007044375A2
(en)
|
2005-10-06 |
2007-04-19 |
Nastech Pharmaceutical Company Inc. |
Pth formulations and methods of use
|
|
EP1991241A4
(en)
*
|
2006-02-23 |
2009-07-08 |
Iomedix Sleep Internat Srl |
COMPOSITIONS AND METHODS FOR INTRODUCING AND MAINTAINING HIGH-QUALITY SLEEPING
|
|
WO2007101161A2
(en)
*
|
2006-02-24 |
2007-09-07 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
ITMI20060629A1
(it)
*
|
2006-03-31 |
2007-10-01 |
Daniele Giovannone |
Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
|
|
AU2007272272B2
(en)
|
2006-07-10 |
2012-04-12 |
Pba3 Biomed Gmbh |
Antimicrobial peptides
|
|
EP2359808B1
(en)
|
2006-08-09 |
2013-05-22 |
Intarcia Therapeutics, Inc |
Osmotic delivery systems and piston assemblies
|
|
BRPI0716261A2
(pt)
|
2006-08-31 |
2013-08-06 |
Novartis Ag |
composiÇÕes farmacÊuticas compreendendo hch para distribuiÇço oral
|
|
JP2010513462A
(ja)
*
|
2006-12-20 |
2010-04-30 |
バイエル・ヘルスケア・エルエルシー |
第ＶＩＩおよび第ＶＩＩａ因子組成物
|
|
WO2008106429A2
(en)
|
2007-02-26 |
2008-09-04 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of heart failure and other disorders
|
|
GB0710321D0
(en)
*
|
2007-05-30 |
2007-07-11 |
Nhs Blood & Transplant |
Method
|
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
|
PE20110543A1
(es)
*
|
2008-08-15 |
2011-08-04 |
Ironwood Pharmaceuticals Inc |
Formulacion solida oral que comprende linaclotida, cation de calcio y leucina
|
|
WO2010027405A2
(en)
*
|
2008-09-04 |
2010-03-11 |
Ironwood Pharmaceuticals, Inc. |
Stable solid formulations of gc-c receptor agonist polypeptides suitable for oral administration
|
|
EP2331077A2
(en)
*
|
2008-09-04 |
2011-06-15 |
Ironwood Pharmaceuticals, Inc. |
Stable forlulation comprising therapeutic polypeptides for oral administration
|
|
US20100221329A1
(en)
|
2008-12-03 |
2010-09-02 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase c agonists and methods of use
|
|
CA2770077A1
(en)
|
2009-08-06 |
2011-02-10 |
Ironwood Pharmaceuticals, Inc. |
Formulations comprising linaclotide
|
|
MX2012001691A
(es)
*
|
2009-08-12 |
2012-02-29 |
Forest Lab Holdings Ltd |
Composiciones de linaclotida que se desintegran oralmente.
|